EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy. - Ali S; Ilyas A; Nazar S; Jha M; Mathur V; Tanweer S; Grover S; Alam O (Naunyn-Schmiedeberg's archives of pharmacology, 2026)